| Patient group | p-value | |
---|---|---|---|
Benign | Malignant | ||
(N = 14) | (N = 16) | ||
Age (mean ± SD) | 45.2 ± 12.7 | 43.9 ± 14.2 | 0.788c |
Menstrual cycle | Â | Â | Â |
  Premenopausal | 7 | 11 | 0.296a |
  Postmenopausal | 7 | 5 |  |
Ascites | Â | Â | Â |
  Absent | 13 | 8 | 0.011a |
  Present | 1 | 8 |  |
Serum marker (median) | Â | Â | Â |
  CA125 (U/ml) | 11.6 | 186.0 | 0.001b |
  KLK10 (ng/ml) | 1.41 | 1.99 | 0.236b |
  KLK6 (ng/ml) | 3.05 | 3.17 | 0.678b |